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Abstract
Background: The urinary metabolic fingerprint of a patent Schistosoma mansoni infection in the mouse has been
characterized using spectroscopic methods. However, the temporal dynamics of metabolic alterations have not
been studied at the systems level. Here, we investigated the systems metabolic changes in the mouse upon
S. mansoni infection by modeling the sequence of metabolic events in urine, plasma and faecal water.
Methods: Ten female NMRI mice, aged 5 weeks, were infected with 80 S. mansoni cercariae each. Ten age- and
sex-matched mice remained uninfected and served as a control group. Urine, plasma and faecal samples were
collected 1 day before, and on eight time points until day 73 post-infection. Biofluid samples were subjected to
1H nuclear magnetic resonance (NMR) spectroscopy and multivariate statistical analyses.
Results: Differences between S. mansoni-infected and uninfected control mice were found from day 41 onwards.
One of the key metabolic signatures in urine and faecal extracts was an alteration in several gut bacteria-related
metabolites, whereas the plasma reflected S. mansoni infection by changes in metabolites related to energy
homeostasis, such as relatively higher levels of lipids and decreased levels of glucose. We identified 12 urinary
biomarkers of S. mansoni infection, among which hippurate, phenylacetylglycine (PAG) and 2-oxoadipate were
particularly robust with regard to disease progression. Thirteen plasma metabolites were found to differentiate
infected from control mice, with the lipid components, D-3-hydroxybutyrate and glycerophosphorylcholine
showing greatest consistency. Faecal extracts were highly variable in chemical composition and therefore only five
metabolites were found discriminatory of infected mice, of which 5-aminovalerate was the most stable and
showed a positive correlation with urinary PAG.
Conclusions: The composite metabolic signature of S. mansoni in the mouse derived from perturbations in urinary,
faecal and plasma composition showed a coherent response in altered energy metabolism and in gut microbial
activity. Our findings provide new mechanistic insight into host-parasite interactions across different compartments
and identified a set of temporally robust biomarkers of S. mansoni infection, which might assist in derivation of
diagnostic assays or metrics for monitoring therapeutic response.
Background
Schistosomiasis is the most important water-based dis-
ease worldwide, and belongs to the neglected tropical dis-
eases. The causative agents are blood flukes of the genus
Schistosoma. Six species parasitize humans, of which
Schistosoma haematobium, S. mansoni and S. japonicum
exhibit the widest geographical distribution, public health
burden and socioeconomic impact [1-3]. Close to 800
million individuals are at risk of schistosomiasis, more
than 200 million are infected and the global burden due
to schistosomiasis might be as high as 4.5 million disabil-
ity-adjusted life years (DALYs) [2,4].
Given the extend of the schistosomiasis problem, and
the fact that treatment relies on a single drug, praziquan-
tel, which raises issues with respect to resistance, there is
an unmet need for acquiring a deeper understanding of
the bidirectional communication between the parasite
and the mammalian host with a view to identifying new
methods of control and potential drug targets. One
potential approach to investigating the developing rela-
tionship between the parasite and its host is metabolic
profiling. Several studies have shown that metabolic
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profiling methods such as 1H nuclear magnetic resonance
(NMR) spectroscopy, ultra-performance liquid chromato-
graphy (UPLC)-mass spectrometry (MS) and capillary
electrophoresis (CE)-MS, coupled with multivariate data
analyses hold promise for probing the metabolic conse-
quences of parasitic infections, including schistosomiasis
in both murine and human hosts [5-8]. Murine models
experimentally infected with either S. mansoni or S. japo-
nicum showed stimulated glycolysis (i.e. increased levels
of pyruvate), and perturbation of the tricarboxylic acid
(TCA) cycle (i.e. decreased concentrations of citrate, suc-
cinate, and 2-oxoglutarate). Alterations in microbiota-
related metabolites (e.g. acetate, butyrate, propionate,
hippurate, p-cresol glucuronide and phenylacetylglycine)
have also been observed indicating cross-talk between
schistosomes, the murine host and its enteric gut micro-
biota [6,9,10]. Some of these findings were replicated in a
recent human cohort study on S. mansoni-infected indi-
viduals in Uganda [5]. Metabonomic investigation of
urinary profiles has also shown infection-related effects
in a range of molecular markers related to energy meta-
bolism and liver function [5]. In addition to prospecting
for biomarkers of infection in readily accessible biofluids
such as urine and faeces, metabolic studies have focused
on integrating biochemical signatures across multiple
biological samples in a move towards a systems biology
approach. This systems-wide application of metabolic
profiling has been adopted in a diversity of fields, such as
pharmaceutical research and development, nutrition, tox-
icology and systems biology, among others [11-13]. Spe-
cific application of metabolic profiling in parasitic
infection biology has been reviewed up to date [7].
In the current study, we expand the metabolic profiling
approach to characterize the dynamic and integrated
response of the murine host to a S. mansoni infection
during acute and chronic stages in urine, plasma and fae-
cal extracts over a 73-day period in order to broaden the
coverage of the metabolome and to ascertain which of
the candidate biomarkers hold promise in terms of early
detection, robustness and sensitivity. Moreover, profiling
of the faecal metabolome may aid in the interpretation of
the reported perturbation in gut microbial metabolism,
thus far expressed via changes in urinary excretion pro-
files. Insight gained at the systems metabolic level will
deepen the understanding of the mechanisms of infection
and disease, and might give rise to novel diagnostic and
prognostic markers of infection or response to treatment.
Methods
Animal model
Details of the S. mansoni-mouse model employed in the
current investigation have been described elsewhere
[14]. In brief, 20 NMRI female mice, aged 3 weeks, were
purchased from RCC (Füllinsdorf, Switzerland) and
group-housed (five animals per cage). Mice had free
access to food pellets (PAB45-NAFAG 9009, Provimi
Kliba; Kaiseraugst, Switzerland) and community tap
water throughout the experiment. Mice were kept under
stable environmental conditions (temperature, ~22°C;
humidity, ~70%; day/night cycle, 12/12 hours). We
adhered to laws of the relevant regional and national
authorities for animal handling, infection, sample collec-
tion, euthanizing and dissection (permission no. 2081).
After an acclimatization period of 2 weeks to avoid
confounding stress-related metabolic activity, half of the
mice (n = 10) were infected subcutaneously with 80
S. mansoni cercariae each. The remaining 10 mice were
left uninfected, and hence served as control group. Mice
were approximately 5 weeks old at the designated day of
infection (day 0) and had a mean weight of 22.9 g
(range: 19.7-24.9 g). One mouse in the control group
became moribund early on in the experiment, and was
hence excluded from all further analyses.
Sample collection
Biofluids were collected between 08:00 and 11:00 hours
in order to minimize diurnal variation in biofluid compo-
sitions. At least 30 μl of urine and two faecal pellets were
collected from each mouse directly into Petri dishes by
gently rubbing their abdomen. Mice failing to let suffi-
cient quantities of either urine or faeces were placed indi-
vidually into sterile empty plastic cages and observed
until sufficiently large quantities of urine and/or faecal
pellets were generated. Urine and faecal samples were
collected into individually labelled Eppendorf tubes, and
immediately transferred onto dry ice prior to storage at
-40°C.
Approximately 45 μl of blood was collected via tail snip
into a haematocrit capillary coated with sodium heparin.
Capillaries were centrifuged at 4,000 g for 5 min and the
packed cell volume (PCV) was recorded. Plasma samples
were transferred into separate Eppendorf tubes, trans-
ferred immediately onto dry ice and subsequently stored
at -40°C.
Sampling of urine, faecal pellets and blood was carried
out nine times over the course of the study, namely 1 day
before infection (D-1) and on days 13, 27, 41, 48, 53, 61,
67 and 73 post-infection, in order to capture the overt
infection as well as early infection stages. Sampling of
non-infected control mice took place at the same time
points.
NMR spectroscopy
A total of 30 μl urine of each sample was mixed with 25 μl
of 0.2 M sodium phosphate buffer (pH = 7.4, 0.01%
sodium 3-(trimethylsilyl) propionate-2,2,3,3-d4 (TSP),
3 mM Na3N) and transferred into a 1.7-mm outer dia-
meter microtube. Two faecal pellets from each mouse at
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each time point were manually homogenized in 700 μl of
the same phosphate buffer in 2-ml Eppendorf tubes.
Homogenates were sonicated at room temperature for
30 min in order to fully dissolve the water-soluble compo-
nents and also reduce the effect of micro-organisms on
the samples. The centrifugation was carried out at 11,000
g for 10 min and 550 μl of supernatant was transferred
into a 5-mm outer diameter glass tube pending NMR ana-
lysis. A total of 25 μl of plasma for each sample was mixed
with 25 μl of saline (D2O:H2O = 9:1, v:v, 0.9% (w/v) NaCl),
and subsequently transferred into 1.7-mm outer diameter
microtubes.
1H NMR spectra were acquired using a Bruker DRX
600 MHz spectrometer (Rheinstetten, Germany) with a
5-mm TXI probe operating at 600.13 MHz. The field was
locked to the 2H resonance of the D2O solvent. In order
to suppress the large water signal, a standard one-dimen-
sional (1-D) NMR pulse [recycle delay (RD)-90°-t1-90°-
tm-90°-acquire free induction decay (FID)] was employed
for the acquisition of all spectra. The water peak was sup-
pressed by selective irradiation during RD of 2 s and mix-
ing time (tm) of 100 ms and t1was fixed to 3 μs. The 90°
pulse length was adjusted to ~10 μs. A total of 256 scans
were recorded into 32 k data points with a spectral width
of 20 ppm. An exponential function was applied to the
FID prior to the Fourier transformation, which induced
line broadening by 0.3 Hz [15]. In order to account for
the smaller molecular components, a Carr-Purcell-Mei-
boom-Gill (CPMG) pulse sequence was applied addition-
ally. Both 1H standard NMR and CPMG spectra were
obtained using the same parameters except that the
CPMG spectra were acquired using a spin-echo pulse
sequence: [RD-90°-(τ-180°-τ)n-acquire FID]. Using this
pulse sequence allows visualization of the low molecular
weight metabolites whilst retaining some residual reso-
nances from the more mobile lipid moieties [16]. For the
CPMG experiment, a spin relaxation delay (2nτ) of
200 ms was used [15]. Diffusion-edited 1H NMR spectra
with water suppression were acquired for selected plasma
samples using the bipolar-pair-longitudinal-eddy-current
pulse sequence. A total of 256 scans were recorded into
16 k data points with a spectral width of 20 ppm. This
experiment was applied to investigate large molecules
present in blood plasma (e.g. lipids) [15]. Due to NMR
time constraints this type of the experiment was only
applied to samples from selected time points.
Additionally, two-dimensional (2D) NMR experiments
(1H-1H correlation spectroscopy [COSY] and 1H-1H
total correlation spectroscopy [TOCSY]) [15], to assist
metabolite identification, were carried out with selected
urine samples. A total of 128 increments with 80 scans
were accumulated into 2 k data points with a spectral
width of 10 ppm for each dimension. The 1H-1H
TOCSY NMR spectra were acquired by using the
MLEV-17 sequence for the spin-lock with a spin-lock
power of 6 kHz.
Data reduction and multivariate data analyses
Spectra were pre-processed consisting of phase and base-
line correction, calibration, digitization, removal of
redundant spectral regions and normalization. For urine
and faecal water, phase and baseline correction was
achieved using an in-house developed MATLAB script
(Dr. T. Ebbels, Imperial College London) and were refer-
enced to the TSP resonance at δ 1H 0.00. Spectral regions
corresponding to δ 1H 0-10.0 were digitized into 20,000
data points with the segment width of 0.0005 ppm and
imported into MATLAB using an in-house developed
MATLAB script (Dr. O. Cloarec, Imperial College Lon-
don). Plasma spectra were processed similarly except that
baseline correction and phasing were performed manu-
ally, whereas the anomeric proton from a-glucose at δ
1H 5.22 was used for calibration. The following spectral
regions were removed to eliminate differences in the effi-
ciency of water suppression, background noise or arte-
facts: for urine δ 1H 0-0.35, δ 1H 3.34-3.38, δ 1H 4.60-
5.05, δ 1H 9.6-10.0 and δ 1H 5.16-6.35; for faecal water δ
1H 4.7-4.9, δ 1H 0-0.3 and δ 1H 9.1-10.0; for plasma δ 1H
3.33-3.36, δ 1H 4.40-5.15, δ 1H 0-0.7 and δ 1H 5.4-10.0.
Subsequently normalization to total spectral area was
carried out prior to employing multivariate data analysis
approaches, including principal component analysis
(PCA) and orthogonal-partial least square-discriminant
analysis (O-PLS-DA) using criteria described elsewhere
[17]. The number of components included in each model
was determined using a cut-off when Q2Y fell below a 5%
increase in cumulative predictive variance explained by
the model. Metabolite assignments were made by use of
2D NMR pulse sequences, in-house chemical shift data-
bases [9] or spiking of chemical standards.
Two urinary metabolites, i.e. hippurate and phenylace-
tylglycine (PAG), were found to be most highly correlated
with the S. mansoni infection. Since these metabolites
reflect gut microbial activity, their relationship with the
faecal water profile was ascertained, using O-PLS regres-
sion analysis employing pre-processed faecal extract spec-
tral data designated as Xmatrix and the integrated
hippurate resonance (δ 1H 7.815-7.858) and the integrated
PAG resonance (δ 1H 7.400-7.446), respectively as the
Ymatrix.
Results
Physiological observation of S. mansoni infection in mice
While the mean PCV of the control group remained con-
stant over the course of the experiment, the mean PCV
of S. mansoni-infected mice showed constant levels up to
day 41 post-infection (PCV = 54.6%) and a slight reduc-
tion on 48 days post-infection (PCV = 46.6%). A steep
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decline occurred thereafter to a level as low as 33.7%
at the end of the experiment, 73 days post-infection
(Figure 1).
The mean S. mansoni worm burden in mice upon dis-
section 73 days post-infection was 36 worms with a
standard deviation of 7 worms. No significant difference
in mean body weight of S. mansoni-infected and non-
infected control mice was observed over the course of
the experiment.
Metabolic profiling and multivariate data analysis on
mouse urine
Two representative 1H NMR spectra of urine, one
obtained from an uninfected control mouse and the sec-
ond one from a S. mansoni-infected mouse 53 days post-
infection, are shown in Figures 2A and 2B. Lactate, lysine,
citrate, 2-oxoglutarate, succinate, 3-ureidopropionic acid,
acetate, trimethylamine, creatine, creatinine, taurine, tri-
methylamine N-oxide (TMAO), alanine, arginine, hippu-
rate, glycine, 2-oxoadipate, 2-oxoisocaproate, 3-methyl-2-
oxovalerate, PAG and 2-oxoisovalerate were identified in
the urinary metabolic spectra of the control mice,
whereas p-cresol glucuronide was only detected in urine
of S. mansoni-infected mice from day 48 post-infection
onwards. Chemical shifts and multiplicities of signals are
summarized in Table 1.
An unsupervised PCA model was generated from the
normalized NMR spectral data acquired from urine
samples of both S. mansoni-infected and non-infected
control mice at all time points using unit variance-
scaled data. A total of three principal components (PCs)
were used to construct the model and cumulatively
explained 38.1% of the total variance (Figure 2C). Mice
at an early stage of infection (≤ 41-day-old infection)
showed similar trajectories to control samples, but from
day 48 post-infection onwards, the infected mice showed
different urinary trajectories along the first PC, forming
a distinct cluster. The corresponding loadings plot indi-
cated that PAG was the main metabolite influencing the
separation between control and early-stage infected
mice and mice at a later stage of infection.
A series of pairwise O-PLS-DA models were con-
structed to model differentiation between S. mansoni-
infected and non-infected mice at each sampling time
point. No difference was observed between early-stage
infected and non-infected control mice as shown in the
PCA scores plot (Figure 2C). However, metabolic distur-
bances were identified in S. mansoni-infected mice from
41 days post-infection onwards. Selected O-PLS-DA
coefficient plots (days 41, 48, 61 and 73 post-infection)
are shown in Figure 3, and the dominant metabolite
changes are summarized in Figure 4. Decreased levels of
urinary hippurate and increased levels of creatine and 3-
ureidopropionate were found in S. mansoni-infected
mice at day 41 post-infection. Later in the experiment,
hippurate levels continued to decrease, together with 2-
oxoadipate, 2-oxoisovalerate, 2-oxoisocaproate and taur-
ine. Whilst PAG concentrations were continuously
higher in infected animals from day 48 post-infection
onwards, p-cresol glucuronide, trimethylamine and
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Figure 1 Graph showing packed cell volume (PCV) ratio of uninfected control and S. mansoni-infected groups of mice across all the
experimental time points. The graph shows a significant decrease in PCV of infected mice from day 48 post-infection onwards. The error bars
represent 2x standard deviation.
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Figure 2 Typical 600 MHz 1H NMR spectra of urine obtained from an uninfected (A) and a S. mansoni-infected (B) mouse at day 53
post-infection. A 3-D PCA trajectory scores plot (C) derived from urinary spectra of both control (black), S. mansoni-infected mice at early stage
(13-41 days post-infection, blue) and these infected mice at the late stage (48-73 days post-infection, red). D and E represent 2-D PCA scores
plots constructed from first and second PCs (D), and first and third PCs (E), respectively.
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Table 1 Identified metabolites in 1H NMR spectra of urine (u), plasma (p) and faecal water (f) obtained from mice with
or without an infection of S.mansoni, together with the respective chemical shifts and signal multiplicities
No Metabolites H group δ 1H (multiplicity*) Biofluids
1 2-oxoadipate b-CH2; g-CH2; δ-CH2 2.77(t); 1.82(m); 2.22(t) u
2 2-oxoglutarate b-CH2; g-CH2 3.01(t); 2.45(t) u
3 2-oxoisocaproate b-CH2; g-CH; 2x CH3 2.61(d); 2.1(m); 0.94(d) u
4 2-oxoisovalerate b-CH; 2x CH3 3.02(m); 1.13(d) u/f
5 3-carboxy-2-methyl-3-
oxopropanamine
b-CH; CH3; g-CH2 2.49(m); 1.08(d); 3.19(m), 3.56(m), 3.72(m) u
6 3-methyl-2-oxovalerate b-CH; b-CH3; g-CH2(i); g-CH2(ii); g-CH3 2.93(m); 1.1(d); 1.7(m); 1.46(m); 0.9(t) u/f
7 3-ureidopropionic acid a-CH2; b-CH2 2.38(t); 3.31(t) u
8 5-aminovalerate a-CH2; b-CH2; g-CH2; δ-CH2 2.24(t); 1.64(m); 1.66(m); 3.02(t) f
9 acetate CH3 1.93(s) u/p/f
10 alanine CH; CH3 3.77(q); 1.47(d) p/f
11 arginine a-CH; b-CH2; g-CH2; δ-CH2 3.78(t); 1.92(m); 1.65(m); 3.20(t) u/f
12 asparagine a-CH; b-CH2 4.01(dd); 2.87(dd),2.95(dd) f
13 aspartate a-CH; b-CH2 3.89(dd); 2.69(dd),2.80(dd) f
14 butyrate a-CH2; b-CH2; CH3 2.16(t); 1.56(m); 0.9(t) f
15 choline N-(CH3)3; a-CH2; b-CH2 3.20(s); 4.07(m); 3.52(m) p/f
16 citrate CH2(i); CH2(ii) 2.66(d); 2.54(d) u/p
17 creatine N-CH3; CH2 3.03(s); 3.92(s) u/p
18 creatinine N-CH3; CH2 3.03(s); 4.05(s) u
19 cytidine 5-CH; 6-CH 6.10(d); 7.85(d) f
20 cytosine 5-CH; 6-CH 5.98(d); 7.51(d) f
21 D-3-hydroxybutyrate a-CH2(i); a-CH2(ii); b-CH; CH3 2.41(dd); 2.31(dd); 4.16(m); 1.2(d) p
22 Dimethylamine 2x CH3 2.72(s) u
23 Glutamate a-CH; b-CH2; g-CH2 3.76(t); 2.07(m); 2.34(m) f
24 Glutamine a-CH; b-CH2; g-CH2 3.78(t); 2.12(m); 2.43(m) p/f
25 glycerophosphorylcholine N-(CH3)3; a-CH2; b-CH2; a’-CH2; b’-CH; g’-CH2 3.22(s); 4.32(t); 3.68(t); 3.61(dd); 3.90(m); 3.72(dd) p
26 glyceryl of lipids CH2OCOR 4.28(m) p
27 Glycine CH 3.55(s) f
28 Hippurate CH2; 2,6-CH; 3,5-CH; 4-CH 3.97(d); 7.84(d); 7.55(t); 7.64 (t) u
29 Isoleucine a-CH; b-CH; b-CH3; g-CH2 (i); g-CH2(ii); CH3 3.68(d); 1.98(m); 1.02(d);1.25(m),1.47(m); 0.94(t) p/f
30 Lactate a-CH; b-CH3 4.11(q);1.32(d) u/p/f
31 Leucine a-CH; b-CH2; g-CH; 2x CH3 3.72(t); 1.74(m), 1.70(m); 0.96(t) p/f
32 lipid fraction CH2C = C 2.0(bs) p
33 lipid fraction CH2C = O 2.22(bs) p
34 lipid fraction C = CCH2C = C 2.75(bs) p
35 lipid fraction CH= CH 5.30(bs) p
36 lipid fraction CH3(CH2)n 0.83(bs) p
37 lipid fraction (CH2)n 1.22(bs) p
38 lipid fraction CH3CH2CH2C = 0.87(bs) p
39 lipid fraction CH2CH2CO 1.57(bs) p
40 Lysine a-CH; b-CH2; g-CH2; δ-CH2; ε-CH2 3.78(t); 1.92(m); 1.72(m); 1.47(m); 3.03(t) u/p/f
41 Methionine a-CH; b-CH2; g-CH2; S-CH3 3.87(t); 2.14(m); 2.63(t); 2.13(s) f
42 N-acetylglycoprotein fraction NHCOCH3 2.06(s) u/f
43 Nicotinurate 2-CH; 6-CH; 4-CH; 5-CH; CH2 8.92(s); 8.70(d); 8.24(d); 7.60(dd); 3.99(s) f
44 p-cresol glucuronide 2,6-CH; 3,5-CH; CH3 7.06(d); 7.23(d); 2.3(s) u
45 Phenylacetylglycine 3,5-CH; 2,4,6-CH; Ar-CH2; N-CH2 7.43 (m); 7.37 (m); 3.75 (d); 3.68 (s) u
46 Phenylalanine 2,6-CH; 3,5-CH; 4-CH; half Ar-CH2; half Ar-
CH2; N-CH
7.33(d); 7.43(m); 7.36(m); 3.17(dd),3.30(dd); 3.99(dd) f
47 Proline a-CH; half b-CH2; half b-CH2; g-CH2; δ-CH2 4.13(dd); 2.08(m), 2.37(m); 2.01(m); 3.38(m) f
48 Propionate CH2; CH3 2.19(m); 1.06(t) f
49 Pyruvate CH3 2.36(s) u/p
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pyruvate levels showed transient increases in urinary
excretion in S. mansoni-infected mice on days 48 and
61. Over the entire course of the infection, hippurate,
PAG, 2-oxoadipate and trimethylamine were found to
be consistently different between the S. mansoni-
infected and the non-infected control mice.
Metabolic profiling and multivariate data analysis on
mouse plasma
Metabolites identified in plasma spectra of non-
infected control mice using either standard 1-D (Figure
5A) or CPMG (Figure 5B) pulse sequences are listed in
Table 1.
Table 1 Identified metabolites in 1H NMR spectra of urine (u), plasma (p) and faecal water (f) obtained from mice with
or without an infection of S.mansoni, together with the respective chemical shifts and signal multiplicities (Continued)
50 scyllo-inositol 6x CH 3.33(s) u/f
51 Succinate 2x CH2 2.41(s) u/f
52 Taurine N-CH2; SO3-CH2 3.43(t); 3.27(t) u/f
53 Threonine a-CH; b-CH; CH3 3.59(d); 4.27(m); 1.32(d) f
54 Trimethylamine 3x CH3 2.89(s) u/f
55 trimethylamine N-oxide 3x CH3 3.28(s) u
56 Tyrosine 2,6-CH; 3,5-CH; a-CH; b-CH2 7.18(d); 6.88(d); 3.94(dd); 3.20(dd), 3.10(dd) f
57 UN 4.11(bs); 3.75(m); 3.65(m) p
58 Uracil 5-CH; 6-CH 5.80(d); 7.52(d) f
59 Valine a-CH; b-CH; g-CH3; g’-CH3 3.62(d); 2.28(m); 0.99(d); 1.04(d) p/f
60 a-glucose 1-H; 2-H; 3-H; 4-H; 5-H; CH2(i); CH2(ii) 5.22(d); 3.54(dd); 3.71(t); 3.42(t); 3.83(ddd); 3.84(m);
3.76(m)
p/f
61 b-glucose 1-H; 2-H; 3-H; 4-H; 5-H; CH2(i); CH2(ii) 4.65(d); 3.24(dd); 3.48(t); 3.40(t); 3.47(ddd); 3.72(dd);
3.90(dd)
p/f
*s, singlet; d, doublet; t, triplet; m, multiplet; q, quadruplet; dd, double doublet; ddd, double double doublet; bs, broad signal.
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Figure 3 O-PLS-DA coefficient plots derived from 1H NMR urinary spectra at day 41 (A), 48 (B), 61 (C) and 73 (D) (Q2Y = 0.58, 0.83,
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An unsupervised pareto-scaled PCA model was calcu-
lated based on the normalized data from 1H standard
(Figure 5C) and CPMG (Figure 5D) plasma spectra,
derived from plasma samples of both control mice, and
mice harbouring a pre-patent (days 13, 27, 34 and 41
post-infection) and a patent S. mansoni infection (days
48, 53, 57, 61, 67 and 73 post-infection). A three compo-
nent model explained 73.7% and 48.1% of the total var-
iance for the standard and CPMG data, respectively. Both
of the scores plots (Figures 5C and 5D) represent a
separation of the chronically S. mansoni-infected mice
from the cluster of the non-infected control mice and
those animals harbouring a pre-patent infection with a
clearer differentiation in the standard than the CPMG
spectral data. The corresponding loadings plots from the
standard and CPMG models (data not shown) generated
a similar ranking of discriminatory metabolites. The
main observed infection discriminating features were
higher levels of lactate and lower levels of N-(CH3)3-
containing compounds, most likely a choline derivative.
Further statistical correlation analysis showed that this
signal was consistent with glycerophosphorylcholine and
phosphatidylcholine, which were found to be higher in
non-infected control mice compared with S. mansoni-
infected mice.
In order to extract further biomarkers of S. mansoni
infection, an O-PLS-DA method was employed on unit
variance-scaled 1-D 1H standard and CPMG on days 13,
27, 34, 41, 48, 53, 61 and 73 post-infection and further
models were calculated for diffusion-edited spectral data
(only on two time points, days 48 and 53 post-infection).
Changes in the plasma composition were observed at day
41 post-infection and at later time points. Strong models
were obtained from standard 1H NMR spectra of plasma
48 days after an infection with Q2Y > 0.9. However, mod-
els derived from CPMG spectral data showed lower
values of Q2Y compared with corresponding O-PLS-DA
models of standard spectral data, with the exception of
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the 41 day post-infection sampling time point. Q2Y
values of O-PLS-DA models of diffusion-edited spectra
on days 48 and 53 were similar to those models of the
standard spectra at the matching examination time
points indicating that the infection induced a change in
the plasma lipid composition.
O-PLS-DA models derived from standard 1H NMR
spectra, CPMG and diffusion-edited spectra of plasma
collected from mice 53 days after infection with S. man-
soni are depicted in Figure 6. A range of lipid fractions
such as CH3CH2CH2C =, (CH2)n, CH2CH2CO, CH2C =
C, CH2CO, C = CCH2C = C, CH2OCOR and -CH=
glucose & amino acids
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CH- were present in higher intensities in the plasma of
S. mansoni-infected mice, whilst lipid signals (e.g. CH3
(CH2)n and CH3CH2CH2) and phosphatidylcholine, con-
firmed by STOCSY [18], were decreased. At day 53
post-infection, lower levels of several low molecular
weight metabolites, including D-3-hydroxybutyrate, acet-
ate and creatine, were observed in both standard and
CPMG 1H NMR spectra of plasma samples derived
from S. mansoni-infected mice, compared to uninfected
control mice. Decreased levels of glucose and citrate
were observed in the CPMG spectral data of the
infected mice.
Metabolic profiling and multivariate data analysis on
faecal water from control and S. mansoni-infected mice
Assignments for representative 1H NMR spectra of fae-
cal water extracts obtained from a non-infected control
mouse and a S. mansoni-infected mouse 53 days after
the infection are shown in Figures 7A and 7B and
include: amino acids (e.g. leucine, valine, alanine, isoleu-
cine, aspartate, glutamine, glutamate, lysine, arginine,
glycine, methionine, phenylalanine and tyrosine), short
chain fatty acids (SCFAs; e.g. butyrate, propionate and
acetate), uracil, 5-aminovalerate, nicotinurate, succinate
and glucose.
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Unsupervised PCA analysis did not yield a clear separa-
tion between the S. mansoni-infected and non-infected
control mice due to large variance in the metabolic pro-
files of faecal extract samples. Significant differentiation in
faecal profiles from infected and non-infected mice was
achieved using pairwise O-PLS-DA models constructed
for each time point based on unit variance-scaled faecal
extract spectral data using one PLS predictive and two
orthogonal components. The coefficient plots (Figures 7C
and 7D) showed the disturbance of a number of metabo-
lites, such as increased propionate, 5-aminovalerate and
N-acetyl glycoprotein signal in S. mansoni-infected mice,
which were apparent from day 48.
Exploration of the correlation between selected urinary
metabolites, discriminatory for infection, and faecal water
profiles
Urinary levels of hippurate and PAG were found to be
consistently disturbed in mice infected with S. mansoni
from days 41 post-infection onwards. Since both these
metabolites derive from gut microbial-host co-metabolism,
an O-PLS regression analysis was applied to the spectral
data of faecal extracts against the relative concentration of
each metabolite in order to characterize the link between
these two urinary metabolites and faecal extract profiles.
O-PLS regression of urinary hippurate against the faecal
extract profiles generated robust models at the following
sampling time points: 48 days post-infection (Q2Y = 0.58,
R2X = 80%) with one predictive component and two
orthogonal components, 53 days post-infection (Q2Y =
0.57, R2X = 39%) and 73 days post-infection (Q2Y = 0.58,
R2X = 29%) with one predictive component and one
orthogonal component. N-acetyl glycoprotein fragments
and propionate were negatively correlated with the urinary
hippurate levels, whilst butyrate was found to be positively
correlated with hippurate at day 73 post-infection (Figure
8). No correlation between hippurate levels and faecal
metabolites were observed at other sampling time points.
O-PLS regression of urinary PAG against the faecal extract
profiles calculated using one aligned and two orthogonal
components generated stronger models than hippurate at
all examination time points: Q2Y = 0.56 and R2X = 63.3%
at day 48 post-infection; Q2Y = 0.80 and R2X = 56.4% at
day 53 post-infection; Q2Y = 0.75 and R2X = 47% at day
61 post-infection; Q2Y = 0.55 and R2X = 53.6% at day 67
post-infection; and Q2Y = 0.76 and R2X = 64.2% at day 73
post-infection. Propionate and 5-aminovalerate were
found to be highly correlated with the urinary PAG levels,
whilst aspartate was negatively associated to PAG at day
61 post-infection (Figure 8).
An O-PLS regression was also performed on biofluid
spectral data obtained at the last time point against worm
burden, but no significant correlation was observed.
Discussion
Dynamic metabolic signatures of mice experimentally
infected with S. mansoni were generated for urine,
plasma and faecal water. In preceding metabolic profil-
ing studies we selected 49 and 56 days post-infection as
sampling time points of overt infection, since previous
studies [19] and in-house investigations revealed that
oviposition occurred, on average, 34-35 days after mice
were infected with S. mansoni. However, literature sug-
gests that there is considerable heterogeneity in the tim-
ing of oviposition in murine models depending on strain
of host and parasite [20]. We therefore extended the
temporal range of sampling to give opportunity for early
detection of response to infection and to generate a
more holistic picture of the emerging infection. In the
current study we detected a significant metabolic
response at 41 days post-infection in both the urine and
the plasma profiles. The key discriminatory urinary
metabolites at this earlier time point were decreased
urinary hippurate and increased levels of creatine and 3-
ureidopropionate, whilst the response in plasma at this
time point was manifested by increased valine and leu-
cine. As the infection developed the global urinary
response observed here was consistent with previous
publications that showed a strong metabolic response at
49 days post-infection consisting of modulation of oxoa-
cids, methylamines, tricarboxylic acid intermediates and
gut microbial-mammalian co-metabolites. The sampling
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Figure 8 Schematic illustration of correlations between faecal
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acetylglycoprotein and butyrate) and urinary hippurate (HP)
and phenylacetylglycine (PAG) levels. A solid line represents
positive correlation between two metabolites, whilst a dashed line
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strategy allowed the construction of metabolic trajec-
tories for each biofluid (Figure 4) and gave an indication
of which metabolic changes persisted throughout the
duration of the infection. Urinary hippurate, PAG and
2-oxoadipate were the most stable predictors of infec-
tion over the experimental period, whereas modulated
levels of 2-oxoisocaproate and trimethylamine in urine,
lipid components and D-3-hydroxybutyrate in plasma
and faecal 5-aminovalerate were robust at the later time
points. A number of metabolites demonstrated a transi-
ent response to infection including urinary taurine and
pyruvate, plasma acetate and lactate, faecal propionate
and N-acetylglycoprotein fragments. These transient
alterations may reflect particular time-dependent
responses to S. mansoni infection or may simply be
more variable in concentration and therefore less robust
as biomarkers.
S. mansoni-induced anaemia in mice
The dramatic decrease in the PCV of mice 48 days after
experimental infection with S. mansoni indicates that ani-
mals suffered from anaemia. There are several possible
mechanisms that might have caused anaemia. For exam-
ple, iron deficiency due to the blood loss in faeces, hepa-
tosplenomegaly resulting in erythrocyte sequestration and
inflammation-related anaemia [21]. These mechanisms are
supported by our current observations, including observa-
tion of blood in faeces from some of the infected mice at
several time points from day 48 post-infection onwards,
spleen enlargement in all the S. mansoni-infected mice on
dissection (histological evidence was reported in a pre-
vious study [14]) and elevated levels of several cytokines,
such as interferon-g (IFN-g), tumor necrosis factor-a
(TNF-a), interleukin-4 (IL-4), IL-5 and IL-12 in plasma in
response to the infection [22]. Although S. mansoni-
induced anaemia could involve multiple mechanisms,
including the consumption of red blood cells by adult
schistosomes, we speculate that splenomegaly and inflam-
mation play key roles, leading to host anaemia, since
blood loss in faeces were only found in some of the
infected mice.
S. mansoni-induced disturbance of phospholipids
metabolism
Phospholipids are believed to act as important mediators
in immunological modification and signal transduction
[23]. Schistosomes are incapable of synthesizing fatty
acids de novo, thus they must absorb and utilize exogen-
ous lipids from the host’s blood and incorporate them
into their membrane structures in order to evade the
host immune response [24]. The decreased level of phos-
pholipids such as phosphatidylcholine in plasma from the
S. mansoni-infected mice could be due to absorption of
phosphatidylcholine by the parasite. Alternatively, the
parasite could provide free choline by its breakdown to
diglycerides synthesized within schistosomes, which may
also explain the lower levels of glycerophosphorylcholine
in plasma of infected mice. This finding is in agreement
with Rumjanek and Simpson’s previous research on lipid
utilization and incorporation by S. mansoni worm in
vitro [25].
S. mansoni-induced energy metabolism disturbance
Several of the metabolic changes observed in the
S. mansoni-infected mice, particularly the finding of
markedly lower concentrations of glucose at certain
time points or increased lactate in plasma from infected
mice suggest an alteration in energy metabolism. Pairs
of adult schistosomes live in the mesenteric veins, where
they depend on glucose uptake from the host to provide
energy for their survival and egg production [26] and
thus the reduction in plasma glucose may simply reflect
increased utilization by the parasite. In our previous
study with a focus on metabolic alterations in tissue
samples obtained from S. mansoni-infected mice 73
days post-infection, we noted high levels of pyruvate
and low levels of glucose and glycogen in livers of S.
mansoni-infected mice [14]. Taken together with the
increased plasma lactate, and the observation that activ-
ities of glycolysis-involved pyruvate kinase and phospho-
fructokinase in the liver were reported to be greater in
S. mansoni-infected mice [27], this would suggest an
infection-induced stimulation of glycolysis.
Urinary levels of 2-oxoisovalerate, 2-oxoisocaproate and
2-oxoadipate were decreased in the current and a previous
study [9]. These three metabolites are known to originate
from valine, leucine and a-aminoadipate, and of these
valine and leucine were found to be accumulated in the
liver from S. mansoni-infected mice [14]. The increase of
these metabolites suggests a disturbance of amino acids
metabolism, and is likely to reflect liver dysfunction.
S. mansoni-induced microbial disturbance
Previous studies profiling the urinary response of rodent
and human hosts to S. mansoni infection have reported
gross disturbance of metabolites associated with either
gut microbial or microbial mammalian co-metabolism
such as increased PAG and decreased hippurate [5]. By
profiling of time-dependent changes in the chemical
composition of faecal extracts and via direct correlation
of the two strongest infection-related urinary indices of
gut microbial metabolism (i.e. PAG and hippurate), we
add further evidence to the hypothesis that S. mansoni
infection either directly or indirectly modulates host gut
microbial activity. As with previous studies, levels of
PAG, hippurate, trimethylamine and p-cresol glucuro-
nide were changed in the urinary profiles following infec-
tion. Both hippurate and PAG are absent in the urine of
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germ-free rats and are observed only after 24-48 hours
and 20 days, respectively, following exposure of these ani-
mals to the laboratory environment indicating their asso-
ciation with microbial metabolism [28]. Hippurate,
formed by conjugation of glycine with benzoate in the
liver mitochondria [29], can be derived from dietary
sources but since the infected and non-infected mice
were supplied with the same diet, and there was no dif-
ference in the mean body weights of these two groups,
this would rather support the alteration of microbial
composition or activity. p-Cresol is a metabolite of pro-
tein degradation and subsequent to its synthesis from tyr-
osine it undergoes hepatic glucuronidation or sulfation
prior to urinary excretion [30]. Its production is subject
to intestinal environment such as composition of micro-
biota, food intake (protein intake, particularly tyrosine)
and pH of the intestinal tract [31]. Clostridium difficile
and Lactobacillus strains are known to produce p-cresol
by decarboxylation of p-hydroxyphenylacetate [32,33].
Thus, elevated urinary levels of p-cresol glucuronide
observed in infected mice may indicate that S. mansoni
could activate those p-cresol-producing bacteria strains
or somehow disrupt the microbial ecology favouring the
presence of activity of p-cresol producing bacteria.
Trimethylamine (TMA) can be derived from dietary
choline via microbial processing and eventually excreted
into the urine after being absorbed by microvillae and
circulated to the kidney via the bloodstream [34].
In addition to the urinary microbial metabolites, several
faecal metabolites also pointed to altered microbial meta-
bolism. 5-Aminovalerate and SCFAs, including propio-
nate, were increased in faecal extract samples from
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infected mice. In particular, 5-aminovalerate was consis-
tently increased and stable changes during the last three
time points. Clostridium sticklandii and C. valericum,
gram-positive anaerobic bacteria belonging to the proteo-
lytic clostridia, can produce 5-aminovalerate from proline
[32,35]. SCFAs originate from bacterial fermentation of
non-digestible starch or oligosaccharides and the produc-
tion of SCFA relies on bacteria species and intestinal
environment (e.g. pH) [36]. Correlations between urinary
and faecal gut microbial metabolites, such as the positive
correlation of urinary hippurate with faecal butyrate or
the negative association between urinary PAG and faecal
propionate, further suggests a coordinated systems
response at the level of the interaction between parasite,
host and enteric microbiota.
The global response derived from the correlation of
metabolic profiles obtained from urine, plasma and faeces
points to both local and systemic effects of S. mansoni
infection (Figure 9), similar to observations on other para-
sitic infections such as Echinostoma caproni [37]. Domi-
nant themes of S. mansoni infection include altered energy
metabolism, gut microbial activity and immunological
response. S. mansoni eggs play a major role in triggering a
variety of host immune responses by secreting glycopro-
teins, glycolipid antigens and unconjugated oligosacchar-
ides [38-40]. Thus the markedly higher amount of N-
acetyl glycoprotein fragments in mice with 67- and 73-
day-old infection, may reflect a response to the eggs rather
than the worms since acute phase glycoproteins have been
associated with inflammation [41].
Conclusion
The systems metabolic change in the mouse due to
S. mansoni infection reported here extends previous
knowledge on the host-parasite interaction in the follow-
ing aspects: (i) changes in urine were observed as early as
41 days post-infection; (ii) plasma and faecal extract pro-
files provide complementary information to urine profiles
on the systemic perturbation induced by S. mansoni
infection and in particular develop the evidence-base for
parasite-induced disruption of gut microbial functional-
ity. This NMR-based metabolic profiling approach
proved useful and robust for monitoring biological
changes in biofluids at the molecular level. Compared
with other host-parasite models studied before, the meta-
bolic interactions between host and parasite shared some
similarities, however, each parasite examined also
demonstrated a unique metabolic signature, which is pro-
mising in terms of developing a robust diagnostic tool for
both individual and population levels.
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